TY - JOUR
T1 - COVID Vaccination in Athletes & Updated Interim Guidance on the Preparticipation Physical Examination during the SARS-CoV-2 Pandemic
AU - Narducci, Dusty Marie
AU - Diamond, Alex B.
AU - Bernhardt, David T.
AU - Roberts, William O.
N1 - Publisher Copyright:
Copyright © 2021 by the American College of Sports Medicine.
PY - 2021/11/1
Y1 - 2021/11/1
N2 - The American Medical Society for Sports Medicine (AMSSM) convened an expert panel to address the current evidence, knowledge gaps, and recommendations surrounding the COVID vaccination in athletes during the SARS-CoV-2 pandemic. The group held a series of meetings beginning in July 2021 and reviewed the available literature while using an iterative process and expert consensus to finalize this guidance statement. This document is intended to provide clinicians with suggestions on how to incorporate the COVID vaccination during the preparticipation physical examination for athletes in all levels of training and competition. The statement is not intended to address treatment, infection control principles, safety, ethical discussion, or public health issues related to SARS-CoV-2. The AMSSM task force acknowledges the clinical uncertainty, evolving public health objectives, and the limited data currently available to create this guidance statement.
AB - The American Medical Society for Sports Medicine (AMSSM) convened an expert panel to address the current evidence, knowledge gaps, and recommendations surrounding the COVID vaccination in athletes during the SARS-CoV-2 pandemic. The group held a series of meetings beginning in July 2021 and reviewed the available literature while using an iterative process and expert consensus to finalize this guidance statement. This document is intended to provide clinicians with suggestions on how to incorporate the COVID vaccination during the preparticipation physical examination for athletes in all levels of training and competition. The statement is not intended to address treatment, infection control principles, safety, ethical discussion, or public health issues related to SARS-CoV-2. The AMSSM task force acknowledges the clinical uncertainty, evolving public health objectives, and the limited data currently available to create this guidance statement.
UR - https://www.scopus.com/pages/publications/85121644219
UR - https://www.scopus.com/pages/publications/85121644219#tab=citedBy
U2 - 10.1249/JSR.0000000000000912
DO - 10.1249/JSR.0000000000000912
M3 - Article
C2 - 34752435
AN - SCOPUS:85121644219
SN - 1537-890X
VL - 20
SP - 608
EP - 613
JO - Current sports medicine reports
JF - Current sports medicine reports
IS - 11
ER -
